Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Med Inc (NQ: NMRD )

0.2340 UNCHANGED
Streaming Delayed Price Updated: 3:57 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nemaura Med Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Nemaura (NASDAQ: NMRD) Marks History-Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks History Making Milestone with Initial Shipment of CGM Devices
Via Investor Brand Network
Nemaura Medical Commences Rollout of Miboko Application
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical is a medical technology... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Commences Rollout of Miboko Application
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution
Via Investor Brand Network
Nemaura Medical Firmly Positioned in Growing Diabetes Tech Market
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Diabetes tech market expanded in 2021... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee
Via Investor Brand Network
Nemaura Medical Launches Miboko – A New Metabolic Health Program
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Launches Miboko – A New Metabolic Health Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Launches Miboko – a New Metabolic Health Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Medical Names Industry Veteran as COO
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Names Industry Veteran as COO
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names Industry Veteran as COO
Via Investor Brand Network
Nemaura Medical to Present at H.C. Wainwright Bioconnect Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) to Present at H.C. Wainwright Bioconnect Conference
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at H.C. Wainwright Bioconnect Conference
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks True Milestone in Development, Growth
Via Investor Brand Network
Nemaura Medical Solutions Empowering People to Take Charge of Well-Being
Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Solutions Empowering People to Take Charge of Well-Being
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Solutions to Empower People to Take Charge of Their Health, Well-Being
Via Investor Brand Network
Nemaura Medical Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee
Nemaura Medical announced the successful completion of its initial shipment of sugarBEAT(R) continuous glucose monitor devices to its UK licensee The initial shipment, which... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee
Via Investor Brand Network
Nemaura Medical Positioned to Benefit from Growth in CGM Market
Nemaura Medical (NASDAQ: NMRD) has developed a platform to monitor multiple chemicals in the blood without needles, replacing traditional invasive methods of diagnosis and health... 
Via Benzinga
Nemaura Medical (NASDAQ: NMRD) Positioned to Benefit from Growth in CGM Market
Via Investor Brand Network
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Positioned to Benefit from Growth in CGM Market
Via Investor Brand Network
54 Biggest Movers From Yesterday
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and... 
Via Benzinga
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Initial Shipment of CGM Devices to MySugarWatch Licensee
Via Investor Brand Network
Nemaura Medical Inc. (NASDAQ: NMRD) Helping Diabetic Individuals Safeguard Themselves From COVID-19
Via Investor Brand Network
Topics Death
Exposures COVID-19 Death
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.